Making medicines affordable
in India

After nearly 10 years of operations, the Medicines Patent Pool (MPP) went to India to see first-hand how access to quality-assured generic medicines for HIV and hepatitis C has changed people’s life.

In the first of our impact series videos, patients, medical experts, governments, among others, explain how MPP’s work has generated impact. From saving lives to increased access, originators, generic manufacturers and committed partners have worked with MPP to deliver the best quality treatments to those who need them most.

Negotiating public-health driven licences with patent holders and sublicensing to generic manufacturers and product developers is the core work of the Medicines Patent Pool.